Selected research
Industry Research
Adapalene Drugs Industry Research Report 2026
Market perspective
The global Adapalene Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Adapalene Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Adapalene Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Adapalene Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Adapalene Drugs include Wuhan Nuoan Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Jiangsu Fubang Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, HEC Pharm, Beijing Foyou Pharmaceutical, Taro Pharmaceutical, Sandoz and Glenmark, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Adapalene Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Adapalene Drugs Market by Company
Wuhan Nuoan Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Jiangsu Fubang Pharmaceutical
Heilongjiang Fuhe Pharmaceutical
HEC Pharm
Beijing Foyou Pharmaceutical
Taro Pharmaceutical
Sandoz
Glenmark
Galderma
Encube Ethicals
Bausch Health
Alembic
Actavis
Adapalene Drugs Segment by Type
Gel
Solution
Cream
Others
Adapalene Drugs Segment by Application
Acne
Keratosis Pilaris
Others
Adapalene Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adapalene Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adapalene Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adapalene Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Adapalene Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Adapalene Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Adapalene Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gel
- Solution
- Cream
- Others
Applications
- Acne
- Keratosis Pilaris
- Others
Companies covered
- Wuhan Nuoan Pharmaceutical
- Sichuan Med-Shine Pharmaceutical
- Jiangsu Fubang Pharmaceutical
- Heilongjiang Fuhe Pharmaceutical
- HEC Pharm
- Beijing Foyou Pharmaceutical
- Taro Pharmaceutical
- Sandoz
- Glenmark
- Galderma
- Encube Ethicals
- Bausch Health
- Alembic
- Actavis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Adapalene Drugs Market Size (2021-2032)
- 2.2.2 Global Adapalene Drugs Sales (2021-2032)
- 2.2.3 Global Adapalene Drugs Market Average Price (2021-2032)
- 2.3 Adapalene Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gel
- 2.3.3 Solution
- 2.3.4 Cream
- 2.3.5 Others
- 2.4 Adapalene Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Acne
- 2.4.3 Keratosis Pilaris
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Adapalene Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Adapalene Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Adapalene Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global Adapalene Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global Adapalene Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Adapalene Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Adapalene Drugs, Product Type & Application
- 3.8 Global Manufacturers of Adapalene Drugs, Established Date
- 3.9 Global Adapalene Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Wuhan Nuoan Pharmaceutical
- 4.1.1 Wuhan Nuoan Pharmaceutical Company Information
- 4.1.2 Wuhan Nuoan Pharmaceutical Business Overview
- 4.1.3 Wuhan Nuoan Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Wuhan Nuoan Pharmaceutical Adapalene Drugs Product Portfolio
- 4.1.5 Wuhan Nuoan Pharmaceutical Recent Developments
- 4.2 Sichuan Med-Shine Pharmaceutical
- 4.2.1 Sichuan Med-Shine Pharmaceutical Company Information
- 4.2.2 Sichuan Med-Shine Pharmaceutical Business Overview
- 4.2.3 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sichuan Med-Shine Pharmaceutical Adapalene Drugs Product Portfolio
- 4.2.5 Sichuan Med-Shine Pharmaceutical Recent Developments
- 4.3 Jiangsu Fubang Pharmaceutical
- 4.3.1 Jiangsu Fubang Pharmaceutical Company Information
- 4.3.2 Jiangsu Fubang Pharmaceutical Business Overview
- 4.3.3 Jiangsu Fubang Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangsu Fubang Pharmaceutical Adapalene Drugs Product Portfolio
- 4.3.5 Jiangsu Fubang Pharmaceutical Recent Developments
- 4.4 Heilongjiang Fuhe Pharmaceutical
- 4.4.1 Heilongjiang Fuhe Pharmaceutical Company Information
- 4.4.2 Heilongjiang Fuhe Pharmaceutical Business Overview
- 4.4.3 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Heilongjiang Fuhe Pharmaceutical Adapalene Drugs Product Portfolio
- 4.4.5 Heilongjiang Fuhe Pharmaceutical Recent Developments
- 4.5 HEC Pharm
- 4.5.1 HEC Pharm Company Information
- 4.5.2 HEC Pharm Business Overview
- 4.5.3 HEC Pharm Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 HEC Pharm Adapalene Drugs Product Portfolio
- 4.5.5 HEC Pharm Recent Developments
- 4.6 Beijing Foyou Pharmaceutical
- 4.6.1 Beijing Foyou Pharmaceutical Company Information
- 4.6.2 Beijing Foyou Pharmaceutical Business Overview
- 4.6.3 Beijing Foyou Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Beijing Foyou Pharmaceutical Adapalene Drugs Product Portfolio
- 4.6.5 Beijing Foyou Pharmaceutical Recent Developments
- 4.7 Taro Pharmaceutical
- 4.7.1 Taro Pharmaceutical Company Information
- 4.7.2 Taro Pharmaceutical Business Overview
- 4.7.3 Taro Pharmaceutical Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Taro Pharmaceutical Adapalene Drugs Product Portfolio
- 4.7.5 Taro Pharmaceutical Recent Developments
- 4.8 Sandoz
- 4.8.1 Sandoz Company Information
- 4.8.2 Sandoz Business Overview
- 4.8.3 Sandoz Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sandoz Adapalene Drugs Product Portfolio
- 4.8.5 Sandoz Recent Developments
- 4.9 Glenmark
- 4.9.1 Glenmark Company Information
- 4.9.2 Glenmark Business Overview
- 4.9.3 Glenmark Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Glenmark Adapalene Drugs Product Portfolio
- 4.9.5 Glenmark Recent Developments
- 4.10 Galderma
- 4.10.1 Galderma Company Information
- 4.10.2 Galderma Business Overview
- 4.10.3 Galderma Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Galderma Adapalene Drugs Product Portfolio
- 4.10.5 Galderma Recent Developments
- 4.11 Encube Ethicals
- 4.11.1 Encube Ethicals Company Information
- 4.11.2 Encube Ethicals Business Overview
- 4.11.3 Encube Ethicals Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Encube Ethicals Adapalene Drugs Product Portfolio
- 4.11.5 Encube Ethicals Recent Developments
- 4.12 Bausch Health
- 4.12.1 Bausch Health Company Information
- 4.12.2 Bausch Health Business Overview
- 4.12.3 Bausch Health Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bausch Health Adapalene Drugs Product Portfolio
- 4.12.5 Bausch Health Recent Developments
- 4.13 Alembic
- 4.13.1 Alembic Company Information
- 4.13.2 Alembic Business Overview
- 4.13.3 Alembic Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Alembic Adapalene Drugs Product Portfolio
- 4.13.5 Alembic Recent Developments
- 4.14 Actavis
- 4.14.1 Actavis Company Information
- 4.14.2 Actavis Business Overview
- 4.14.3 Actavis Adapalene Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Actavis Adapalene Drugs Product Portfolio
- 4.14.5 Actavis Recent Developments
5 Global Adapalene Drugs Market Scenario by Region
- 5.1 Global Adapalene Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Adapalene Drugs Sales by Region: 2021-2032
- 5.2.1 Global Adapalene Drugs Sales by Region: 2021-2026
- 5.2.2 Global Adapalene Drugs Sales by Region: 2027-2032
- 5.3 Global Adapalene Drugs Revenue by Region: 2021-2032
- 5.3.1 Global Adapalene Drugs Revenue by Region: 2021-2026
- 5.3.2 Global Adapalene Drugs Revenue by Region: 2027-2032
- 5.4 North America Adapalene Drugs Market Facts & Figures by Country
- 5.4.1 North America Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Adapalene Drugs Sales by Country (2021-2032)
- 5.4.3 North America Adapalene Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Adapalene Drugs Market Facts & Figures by Country
- 5.5.1 Europe Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Adapalene Drugs Sales by Country (2021-2032)
- 5.5.3 Europe Adapalene Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Adapalene Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Adapalene Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Adapalene Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Adapalene Drugs Market Facts & Figures by Country
- 5.7.1 South America Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Adapalene Drugs Sales by Country (2021-2032)
- 5.7.3 South America Adapalene Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Adapalene Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Adapalene Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Adapalene Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Adapalene Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Adapalene Drugs Sales by Type (2021-2032)
- 6.1.1 Global Adapalene Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Adapalene Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global Adapalene Drugs Revenue by Type (2021-2032)
- 6.2.1 Global Adapalene Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Adapalene Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global Adapalene Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Adapalene Drugs Sales by Application (2021-2032)
- 7.1.1 Global Adapalene Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Adapalene Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global Adapalene Drugs Revenue by Application (2021-2032)
- 7.2.1 Global Adapalene Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Adapalene Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global Adapalene Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Adapalene Drugs Value Chain Analysis
- 8.1.1 Adapalene Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Adapalene Drugs Production Mode & Process
- 8.2 Adapalene Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Adapalene Drugs Distributors
- 8.2.3 Adapalene Drugs Customers
9 Global Adapalene Drugs Analyzing Market Dynamics
- 9.1 Adapalene Drugs Industry Trends
- 9.2 Adapalene Drugs Industry Drivers
- 9.3 Adapalene Drugs Industry Opportunities and Challenges
- 9.4 Adapalene Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst